Clinical trial

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

NCT00272558

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Carboplatin and Vinorelbine Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-09-01

PhasePHASE2

Conditions

Malignant Pleural Mesotheliomaverified · MONDO: malignant pleural mesothelioma

Interventions

Carboplatin and VinorelbineDRUG

Sponsors & collaborators

Copenhagen University Hospital, Rigshospitaletlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00272558 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.